ACCD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ACCD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accolade has the Growth Rank of 8.
GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:
1. 5-year revenue growth rate, the higher, the better.A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.
GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.
Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.
For the Health Information Services subindustry, Accolade's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Accolade's Growth Rank distribution charts can be found below:
* The bar in red indicates where Accolade's Growth Rank falls into.
Thank you for viewing the detailed overview of Accolade's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Stephen H. Barnes | officer: Chief Financial Officer | C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462 |
Rajeev Singh | director, officer: Chief Executive Officer | 6222 185TH AVENUE NE, REDMOND WA 98052 |
Robert N Cavanaugh | officer: President | 1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404 |
Richard Eskew | officer: EVP General Counsel | C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462 |
Mchugh Colin | officer: Chief Accounting Officer | C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462 |
Michael W Hilton | officer: Chief Product Officer | 6222 185TH AVE, REDMOND WA 98052 |
Peter S Klein | director | C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399 |
Cindy Kent | director | 7601 PENN AVENUE SOUTH, RICHFIELD MN 55418 |
Patricia L Wadors | director | C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050 |
Dawn G Lepore | director | 1425 BROADWAY PMB 41, SEATTLE WA 99122 |
Jeffrey D Jordan | director | 2865 SAND HILL ROAD #101, MENLO PARK CA 94025 |
Elizabeth G Nabel | director | BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115 |
Jeffrey S Brodsky | director | C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036 |
Thomas J Neff | director | SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172 |
William H. Frist | director | 600 MONTGOMERY STREET, SAN FRANCISCO CA 94111 |
From GuruFocus
By PRNewswire • 01-08-2025
By Business Wire • 01-08-2025
By Marketwired • 02-24-2025
By PRNewswire • 01-14-2025
By Marketwired • 11-13-2024
By PRNewswire • 03-06-2025
By GlobeNewswire • 02-24-2025
By Business Wire • 02-25-2025
By PRNewswire • 02-13-2025
By PRNewswire • 02-12-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.